127 related articles for article (PubMed ID: 10552217)
1. PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo.
Herbst RA; Podewski EK; Mommert S; Kapp A; Weiss J
Arch Dermatol Res; 1999 Oct; 291(10):567-9. PubMed ID: 10552217
[No Abstract] [Full Text] [Related]
2. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
3. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
4. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
[No Abstract] [Full Text] [Related]
5. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
6. Partial trisomy 10q with mild phenotype caused by an unbalanced X;10 translocation.
Mononen T; Sharp A; Laakso M; Meltoranta RL; Valve-Dietz AK; Heinonen K
J Med Genet; 2003 May; 40(5):e61. PubMed ID: 12746415
[No Abstract] [Full Text] [Related]
7. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK
Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646
[TBL] [Abstract][Full Text] [Related]
8. Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1?
Siebert R; Gesk S; Harder S; Plötz S; Matthiesen P; Grote W; Schlegelberger B; Jandrig B; Grasmo-Wendler UH; Scherneck S; Rosenwald A; Ott G
Blood; 1998 Dec; 92(11):4487-9. PubMed ID: 9882102
[No Abstract] [Full Text] [Related]
9. The PTEN tumour suppressor gene and malignant melanoma.
Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of PTEN and MXI1 in primary bladder carcinoma.
Wang DS; Rieger-Christ K; Latini JM; Moinzadeh A; Stoffel J; Pezza JA; Saini K; Libertino JA; Summerhayes IC
Int J Cancer; 2000 Nov; 88(4):620-5. PubMed ID: 11058880
[TBL] [Abstract][Full Text] [Related]
11. Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas.
Herranz M; Urioste M; Santos J; Martinez-Delgado JB; Rivas C; Benitez J; Fernández-Piqueras J
Leukemia; 2000 Jul; 14(7):1325-7. PubMed ID: 10914564
[No Abstract] [Full Text] [Related]
12. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
[TBL] [Abstract][Full Text] [Related]
14. Identification of PTEN mutations in metastatic melanoma specimens.
Celebi JT; Shendrik I; Silvers DN; Peacocke M
J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
[TBL] [Abstract][Full Text] [Related]
15. The chromosome 10 monosomy common in human melanomas results from loss of two separate tumor suppressor loci.
Robertson GP; Herbst RA; Nagane M; Huang HJ; Cavenee WK
Cancer Res; 1999 Aug; 59(15):3596-601. PubMed ID: 10446968
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
19. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
[TBL] [Abstract][Full Text] [Related]
20. PTEN/MMAC1 expression in melanoma resection specimens.
Deichmann M; Thome M; Benner A; Egner U; Hartschuh W; Näher H
Br J Cancer; 2002 Dec; 87(12):1431-6. PubMed ID: 12454773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
